Randomized Trialhigh evidence
Autonomous Oxygen Titration for Maintaining Normoxemia in Acutely Ill Adults: The SAVE-O2 AI Randomized Clinical Trial.
JAMA internal medicine·August 3, 2026·PMID 42546017
Why it mattersMaintaining normoxemia in hospitalized patients is challenging with intermittent manual adjustments, often leading to unintended hypoxemia or hyperoxemia. This trial demonstrates that an autonomous closed-loop system can more precisely control oxygenation, potentially reducing both hypoxic and hyperoxic exposure—factors linked to adverse outcomes in critical illness.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled